iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDD) Trading 0.6% Higher – Time to Buy?

iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDDGet Free Report) shares shot up 0.6% during trading on Thursday . The stock traded as high as $35.71 and last traded at $35.57. 14,442 shares traded hands during mid-day trading, an increase of 13% from the average session volume of 12,817 shares. The stock had previously closed at $35.37.

iShares LifePath Target Date 2040 ETF Stock Up 0.5%

The firm has a 50-day simple moving average of $35.43 and a 200-day simple moving average of $34.27. The stock has a market cap of $52.21 million, a PE ratio of 20.77 and a beta of 0.74.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iShares LifePath Target Date 2040 ETF stock. Sunbelt Securities Inc. purchased a new stake in shares of iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDDFree Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 2,254 shares of the company’s stock, valued at approximately $79,000. Sunbelt Securities Inc. owned 0.15% of iShares LifePath Target Date 2040 ETF as of its most recent SEC filing.

About iShares LifePath Target Date 2040 ETF

(Get Free Report)

The iShares LifePath Target Date 2040 ETF (ITDD) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2040 ITDD was launched on Oct 17, 2023 and is issued by BlackRock.

Read More

Receive News & Ratings for iShares LifePath Target Date 2040 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2040 ETF and related companies with MarketBeat.com's FREE daily email newsletter.